Compare OI & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OI | BHC |
|---|---|---|
| Founded | 1903 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | N/A | N/A |
| Metric | OI | BHC |
|---|---|---|
| Price | $16.45 | $5.71 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $17.43 | $8.67 |
| AVG Volume (30 Days) | 1.5M | ★ 2.2M |
| Earning Date | 02-10-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.97 |
| Revenue | $6,455,000,000.00 | ★ $10,029,000,000.00 |
| Revenue This Year | $1.39 | $6.81 |
| Revenue Next Year | $1.43 | $4.11 |
| P/E Ratio | ★ N/A | $5.92 |
| Revenue Growth | N/A | ★ 5.86 |
| 52 Week Low | $9.23 | $4.25 |
| 52 Week High | $16.69 | $8.69 |
| Indicator | OI | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 66.41 | 34.44 |
| Support Level | $14.91 | $5.62 |
| Resistance Level | $16.69 | $5.85 |
| Average True Range (ATR) | 0.45 | 0.20 |
| MACD | 0.09 | -0.05 |
| Stochastic Oscillator | 92.93 | 19.35 |
O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.